Effects of antihypertensive drugs on renal function in patients with diabetic nephropathy

American Journal of Hypertension

Volumn 10, Issue 9 SUPPL. 1, 1997, Pages 208S-217S

  Bretzel, Reinhard G ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Antihypertensive therapy; Diabetic nephropathy; Hypertension; Insulin dependent diabetes mellitus (IDDM); Non insulin dependent diabetes mellitus (NIDDM); Renal function

Indexed keywords

CALCIUM ANTAGONIST; CAPTOPRIL; CILAZAPRIL; CLOTIAZEPAM; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ISRADIPINE; LISINOPRIL; NICARDIPINE; NIFEDIPINE; NITRENDIPINE; PERINDOPRIL; TRANDOLAPRIL; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; COST BENEFIT ANALYSIS; DIABETIC NEPHROPATHY; DRUG MIXTURE; GENETIC PREDISPOSITION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPOPROTEINEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY FUNCTION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR;

ANTIHYPERTENSIVE AGENTS; CLINICAL TRIALS; DIABETIC NEPHROPATHIES; DRUG COSTS; DRUG THERAPY, COMBINATION; HUMANS; KIDNEY;

EID: 0030750485     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(97)00155-6     Document Type: Article

References (103)

1. US Renal Data System: USRDS 1994 Annual Data Report. Incidence and Causes of Treated Renal Disease. Am J Kidn Dis 1994;24(suppl 2):S48-S56.
2. Valderrabano F: EDTA Registry annual report on management of renal failure in Europe, XXIV, 1993. European Dialysis and Transplantation Association Annual Congress 1994: Vienna.
3. Koch M, Thomas B, Tschoeppe W, Ritz E: Diabetes mellitus accounts for an ever-increasing proportion of the patients admitted for renal replacement therapy (letter). Nephrol Dial Transplant 1989;4:399.
4. Lippert J, Ritz E, Schwarzbeck A, Schneider P: The rising tide of end-stage renal failure from diabetic nephropathy type 2 - an epidemiological analysis. Nephrol Dial Transplant 1995;10:462-467.
5. Hasslacher C, Ritz E, Wahl P, Michael C: Similar risks of nephropathy in patients with type 1 or type 2 diabetes mellitus. Nephrol Dial Transplant 1989;4:859-863.
6. Zimmet P, McCarthy D: The NIDDM epidemic: global estimates and projections - a look into the crystal ball. IDF Bulletin 1995;40:8-16.
7. Bretzel, RG: Die diabetische Nephropathie. Med Welt 1987;38:570-576.
8. Bretzel RG: Hypertonie bei Diabetes mellitus. Med Welt 1991;42:397-403.
9. Hasslacher C, Stech W, Wahl P, Ritz E: Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1985;28:6-11.
10. Baba T, Murabaiashi S, Tomejama T, Takebe K: Uncontrolled hypertension is associated with rapid progression of nephropathy in type 2 diabetic patients with proteinuria and preserved renal function. Tohoku J Exp Med 1990;161:311-318.
11. Working Group on Hypertension: Statement on hypertension in diabetes. Diabetes Care 1987;10:764-776.
12. Adler S, Nast C, Artishewsky A: Diabetic nephropathy: pathogenesis and treatment. Ann Rev Med 1993; 44:303-315.
13. Hostetter TH: Mechanisms of diabetic nephropathy. Am J Kidney Dis 1994;23:188-192.
14. Brownlee M, Vlassara H, Cerami A: Non-enzymatic glycosylation and the pathogenesis of diabetic complications. Ann Int Med 1984;101:527-537.
15. Cerami A, Vlassara H, Brownlee M: Role of advanced glycosylation products in complications of diabetes. Diabetes Care 1988;11(suppl 1):73-79.
16. Microalbuminuria Collaborative Study Group, United Kingdom: Risk factors for development of microalbuminuria in insulin-dependent diabetic patients: a cohort study. Br Med J 1993;306:1235-1239.
17. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989;320:1161-1165.
18. Pettitt DJ, Saad MF, Bennett PH, et al: Familial predisposition to renal disease in two generations of Pima Indians with type II (non-insulin-dependent) diabetes mellitus. Diabetologia 1990;33:438-443.
19. Marre M, Bernadet P, Gallois Y, et al: Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994;43:3-388.
20. Schmidt S, Schöne N, Ritz E, and the Diabetic Nephropathy Study Group: Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 1995;47:1176-1181.
21. Krolewski AS, Canessa M, Warram JH, et al: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988;318:140-145.
22. Mangili R, Bending JJ, Scott G, et al: Increased sodium-lithium countertransport activity in red cells in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1988;318:146-150.
23. Jensen JS, Mathiesen ER, Norgaard K, et al: Increased blood pressure and erythrocide sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia 1990;33:619-624.
24. Elving LD, Wetzels JFM, Denobel E, Berden JHM: Erythrocide sodium-lithium countertransport is not different in T 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia 1991;34:126-128.
25. Sharma K, Ziyadeh FM: Hyperglycemia and diabetic kidney disease: the case for transforming growth factor beta as a key mediator. Diabetes 1995;44:1139-1146.
26. Nakamura T, Ebihara I, Fukui M, et al: Messenger RNA expression for growth factors in glomeruli from focal glomerular sclerosis. Clin Immunol Immunopathol 1993;66:33-42.
27. Yamamoto T, Noble NA, Miller DE, Border WA: Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int 1994; 45:916-927.
28. Sharma K, Ziyadeh FN: The transforming growth factor-beta system and the kidney. Semin Nephrol 1993; 13:116-128.
29. Bollineni JS, Reddi AS: Transforming growth factor-beta 1 enhances glomerular collagen synthesis in diabetic rats. Diabetes 1993;42:1673-1677.
30. Riser BL, Cortes P, Zhao X, et al: Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992; 90:1932-1943.
31. Cortes P, Riser BL, Zhao X, Narins RG: Glomerular volume expansion and mesangial cell mechanical strain: mediators of glomerular pressure injury. Kidney Int 1994;(suppl)45:S11-16.
32. Bretzel RG, Leferink H, Timpl R, Federlin K: Diagnostische Bedeutung von Basalmembranfragmenten im Serum als Marker der diabetischen Glomerulosklerose. Verh Dtsch Ges Inn Med 1982;88:811-815.
33. Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982;72:375-380.
34. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986;77:1993-2000.
35. Border WA, Okuda S, Languino LR, Ruoslahti E: Transforming growth factor-beta regulates productioni of proteoglycans by mesangial cells. Kidney Int 1990;37:689-695.
36. Okuda S, Nakamura T, Yamamoto T, et al: Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis. Proc Natl Acad Sci USA 1991;88:9765-9769.
37. Fukui M, Nakamura T, Ebihara I, et al: Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-beta in experimental glomerular sclerosis. J Lab Clin Med 1993;121:224-234.
38. Dworkin LD, Benstein JA, Parker M, et al: Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms. Kidney Int 1993; 43:808-814.
39. Hansen KF, Dahl-Jorgensen K, Lauritzen T, et al: Diabetic control and microvascular complications: the near normoglycemic experience. Diabetologia 1986;29: 677-684.
40. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
41. Reichart P, Nilsson BY, Rosenquist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-309.
42. Ohkubo Y, Kishikawa H, Araki E, et al: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-117.
43. Krolewski AS, Warram JH, Christlieb AR: Hypercholesterolemia - a determinant of renal function loss and death in IDDM patients with nephropathy. Kidney Int 1994;45(suppl 45):S1257-S131.
44. Mulec H, Johnson S, Bjolk S: Relationship between serum cholesterol and diabetic nephropathy. Lancet 1990;335:1537-1538.
45. Rabelink AJ, Hene RJ, Erkelens DW, et al: Partial remission of nephrotic syndrome in patient on long-term simvastatin (letter). Lancet 1990;335:1045-1046.
46. Sasaki T, Kurata H, Nomura K, et al: Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus. Jpn J Med 1990;29: 156-163.
47. Walker J, Dodds R, Murrells P, et al: Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 1989;ii:1411-1415.
48. Zeller K, Whittaker E, Sullivan L, et al: Effect of restricting dietary protein on progression of renal failure in patients with insulin-dependent forms. N Engl J Med 1991;324:78-84.
49. Klahr S, Levey AS, Beck GJ, et al: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994;330:877-884.
50. Sugimoto T, Kikkawa R, Haneda M, Shigeta Y: Effect of dietary protein restriction on proteinuria in non-insulin-dependent diabetic patients with nephropathy. J Nutr Sci Vitaminol 1991;37(suppl):S87-S92.
51. Sawicki PT, Didjurgeit U, Mühlhauser I, et al: Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994;17:126-131.
52. Almdahl T, Nygard K, Feldt-Rasmussen B, Deckert T: The predictive value of microalbuminuria in IDDM. Diabetes Care 1994;17:120-125.
53. Olivarius NdF, Andreasen AH, Keiding N, Mogensen CE: Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice", Denmark. Diabetologia 1993;36:1007-1016.
54. Savage S, Nagel NJ, Estacio RO, et al: Clinical factors associated with urinary albumin excretion in type II diabetes. Am J Kidney Dis 1995;25:836-844.
55. Biesenbach G, Janko O, Zazgornik J: Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. Nephrol Dial Transplant 1994;9: 1097-1102.
56. Taguma Y, Kitamoto Y, Futaki G, et al: Effect of captopril on heavy proteinuria in azothemic diabetics. N Engl J Med 1985;313:1617-1620.
57. Björck S, Mulec H, Johnsen SA, et al: Renal protective effect of enalapril in diabetic nephropathy. Br Med J 1992;304:339-343.
58. De Cesaris R, Ranieri G, Filitti V, et al: Effects of athenolol and enalapril on kidney function in hypertensive diabetic patients. J Cardiovasc Pharmacol 1993;22:208-214.
59. Slataper R, Vicknair N, Sadler R, Bakris GL: Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med 1993;153:973-980.
60. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.
61. Norgaard K, Jensen T, Christensen P, Feldt-Rasmussen B: A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension. Blood Press 1993;2:301-308.
62. Bakris GL, Barnhill BW, Sadler R: Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int 1992;41:912-919.
63. Slataper R, Vicknair N, Sadler R, Bakris GL: Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med 1993;153:973-980.
64. Stornello M, Valvo EV, Scapelato L: Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipin and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy. J Cardiovasc Pharmacol 1989;14:851-855.
65. Bakris GL: Effects of diltiazem or lisinopril in massive proteinuria associated with diabetes mellitus. Ann Intern Med 1990;112:707-708.
66. Bakris GL: Hypertension in diabetic patients. An overview of interventional studies to preserve renal function. Am J Hypertens 1993;6:140S-147S.
67. Kasiske BL, Kalil RS, Ma JZ, et al: Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993; 118:129-138.
68. Böhlen L, De Courten M, Weidmann P: Comparative study of the effect of ACE-inhibitors and other antihypertensive agents on proteinuria in diabetic patients. Am J Hypertens 1994;7(suppl):84S-92S.
69. Hur C, Appel LJ, Coresh J: The impact of angiotensin-converting enzyme inhibitor therapy on renal function in diabetics: results of a metaanalysis. Am J Hypertens 1995;8:131-137.
70. Weidmann P, Schneider M, Böhlen L: Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated metaanalysis. Nephrol Dial Transplant 1995;10(suppl 9):39-45.
71. Jungmann E, Haak T, Malanyn M, et al: Comparative study on renal effects of nitrendipine vs enalapril in microalbuminuric patients with type I diabetes mellitus (abst). Diabetologia 1992;35(suppl 1):A149.
72. Ruggenenti P, Mosconi L, Bianchi L, et al: Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients. Am J Kidney Dis 1994;24:753-761.
73. Bretzel RG, Bollen CC, Mäser E, Federlin KF: Nephroprotective effects of nitrendipine in hypertensive type I and type II diabetic patients. Am J Kidney Dis 1993; 21(suppl 3)53-64.
74. Christensen CK, Mogensen CE: Antihypertensive treatment: long-term reversal of progression of albuminuria in incipient diabetic nephropathy: a longitudinal study of renal function. J Diabetes Complications 1987;1:45-52.
75. Janka HU, Weitz TH, Blümner E, et al: Hypertension and microalbuminuria in diabetic patients taking indapamide. J Hypertens 1989;7(suppl 6):S316-S317.
76. Gambardella S, Frontoni S, Felici MG, et al: Efficacy of antihypertensive treatment with indapamide in patients with non-insulin-dependent diabetes and persistent microalbuminuria. Am J Cardiol 1990;65:46H-50H.
77. Melbourne Diabetic Nephropathy Study Group: Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Br Med J 1991;302:210-216.
78. Hermans MP, Brichard SM, Colin I, et al: Long-term reduction of microalbuminuria after three years of angiotensin converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients. Am J Med 1992;92(suppl 4B):102-107.
79. Chan JCN, Cockram CS, Nicholls MG, et al: Comparison of enalapril and nifedipine in treating non-insulin-dependent diabetes associated with hypertension: one-year analysis. Br Med J 1992;305:981-985.
80. Velussi M, Brocco E, Frigato F, et al: Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Diabetes 1996;45:216-222.
81. Agardh CD, Garcia-Puig J, Charbonnel B, et al: Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine. J Hum Hypertens 1996;10:185-192.
82. Mathiesen ER, Hommel E, Giese J, Parving HH: Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. Br Med J 1991;303:81-87.
83. Laffel L, Gans DJ, McGill JB, on behalf of the Captopril Nephropathy Study Group: Captopril decreases the rate of progression of renal disease in normotensive, insulin-dependent diabetes mellitus (IDDM) patients with microalbuminuria. J Am Soc Nephrol 1993;4: 304(abstr).
84. Viberti GC, Mogensen CE, Groop LC, Pauls JF, for the European Microalbuminuria Captopril Study Group: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994;271:275-279.
85. The Microalbuminuria Captopril Study Group: Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. Diabetologia 1996;39: 587-593.
86. Marre M, Chatelier G, Leblanc H, et al: Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 1988;297: 1092-1095.
87. Ravid M, Savin H, Jutrin I, et al: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993;118: 577-581.
88. Hallab M, Gallois Y, Chatelier G, et al: Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin-independent diabetes. Br Med J 1993;306:175-182.
89. Schnack C, Capek M, Banyai M, et al: Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients. Acta Diabetol 1994;31: 14-18.
90. The EUCLID Study Group: Randomized placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997;345:1787-1792.
91. Stornello M, Valvo EV, Scapelato L: Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy. J Cardiovasc Pharmacol 198;14:851-855.
92. Bakris GL, Barnhill BW, Sadler R: Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int 1992;41:912-919.
93. Fioretto P, Frigato F, Velussi M, et al.: Effects of angiotensin-converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients. Am J Hypertens 1992;5:837-846.
94. Carmines PK, Navar LG: Disparate effects of Ca channel blockade on efferent and efferent arteriolar responses to ANG II. Am J Physiol 1989;256:F1015-F1020.
95. Brown S, Walton C, Crawford P, Bakris GL: Comparative renal hemodynamic effects of an ACE-inhibitor or calcium antagonist on progression of diabetic nephropathy in a dog. Kidney Int 1993;43:1210-1218.
96. Gaber L, Walton C, Brown S, Bakris GL: Effect of antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs. Kidney Int 1994;46:161-169.
97. Raij L: Effects of ACE inhibitors and calcium channel blockers on the development of glomerular sclerosis in models of renal damage. Nephrol Dial Transplant 1995;10(suppl 9):23-27.
98. Nichols C, Amman K, Törnig J, et al: Differential effects of hypertensive treatment on the development of glomerulosclerosis in subtotally nephrectomized rats (abst). J Am Soc Nephrol 1994;5:790A.
99. Munter K, Hergenröder S, Jochims K, Kirchengast M: Individual and combined effects of verapamil or trandolapril on attenuating hypertensive glomerulopathic changes in a stroke-prone rat. J Am Soc Nephrol 1996; 7:1-6.
100. Munter K, Gries J, Hergenröder S, Kirchengast M: Nephroprotection increases survival in stroke-prone spontaneously hypertensive rats. Pharm Pharmacol Lett 1995;5:146-149.
101. Schneider M, Lerch M, Papiri M, et al: Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes. J Hypertens 1996;14:669-677.
102. Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE: Is screening and intervention for microalbuminuria worthwhile in patients with insulin-dependent diabetes? Br Med J 1993;306:1722-1723.
103. Rodby R, Furth L, Lewis E: An economic analysis of captopril in the treatment of diabetic nephropathy (abst). J Am Soc Nephrol 1994;5:382.